Corbus Pharmaceuticals Holdings (CRBP) Current Assets (2013 - 2025)

Corbus Pharmaceuticals Holdings' Current Assets history runs 13 years deep, the most recent figure standing at $167.0 million for Q4 2025.

• On a quarterly basis, Current Assets rose 9.14% year-over-year to $167.0 million in Q4 2025; TTM through Dec 2025 was $167.0 million, a 9.14% increase from a year earlier, with the FY2025 full-year figure at $167.0 million, up 9.14% from the prior year.
• Current Assets advanced to $167.0 million in Q4 2025 per CRBP's latest filing, from $107.6 million in the prior quarter.
• Across five years, Current Assets topped out at $167.0 million in Q4 2025 and bottomed at $23.5 million in Q4 2023.
• The 5-year median for Current Assets is $109.6 million (2021), against an average of $100.1 million.
• Across the five-year window, Current Assets sank 60.87% in 2023 and surged 549.69% in 2024, its largest moves.
• Year by year, Current Assets stood at $100.2 million in 2021, then sank by 39.94% to $60.2 million in 2022, then sank by 60.87% to $23.5 million in 2023, then jumped by 549.69% to $153.0 million in 2024, then gained by 9.14% to $167.0 million in 2025.
• Per Business Quant, the three latest CRBP Current Assets figures stand at $167.0 million (Q4 2025), $107.6 million (Q3 2025), and $122.8 million (Q2 2025).